Trademarkia Logo

Canada

C$
Trademark Search in Canada
EASYMERS

View On IC.GC.CA

EASYMERS
SEARCHED

on 6 Sept 2022

Last Applicant/ Owned by

IMMUNAWARE APS

Agern Alle 1DK-2970 Hørsholm

DK

Serial Number

2111343 filed on 11th Feb 2021

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

EASYMERS

Trademark usage description

reagents for immunoanalysis, not for medical use; chemical products for diagnostic, industrial and scientific purposes; diagnostic reagents for diagno Read More

Classification Information

Class [001]
Reagents for immunoanalysis, not for medical use; chemical products for diagnostic, industrial and scientific purposes; diagnostic reagents for diagnostic (not medical and veterinary) and scientific purposes; research reagents for scientific and diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes (not for medical and veterinary purposes); biochemical reagents (not for medical and veterinary purposes); chemical reagents, other than for medical and veterinary purposes; biochemical diagnostic kits for scientific and diagnostic purposes (not for medical and veterinary purposes); biochemical analysis kits for research and diagnostic purposes (not for medical and veterinary purposes); biochemical analysis preparations for scientific purposes related to vaccines and immunotherapy, namely cancer therapy, cancer immunotherapy, analysis and treatment of cancer, infectious diseases and autoimmunity, and for use in connection with toxicological studies, transplantation, and immune monitoring (e.g. T cell monitoring).

Classification kind code

11

Class [005]
Reagents for immunoanalysis for medical use, namely for detection of specific T cells and T cell responses in cancer and infectious diseases and autoimmune diseases and transplantation reactions; reagents for pharmaceutical purposes, namely for manipulation of specific T cells in cancer and infectious diseases and autoimmune diseases and transplantation reactions; reagents for preparations for medical purposes, namely in cancer and infectious diseases and autoimmune diseases and transplantation reactions; reagents for diagnostic preparations for medical purposes, namely in cancer and infectious diseases and autoimmune diseases and transplantation reactions; vaccines; biochemical analysis preparations for medical purposes for the above preparations for development and analysis of vaccines, immunotherapy and cellular therapy, respectively cancer vaccines and cancer immunotherapy, and T cell therapies; biochemical analysis preparations for use in cancer therapy and other therapy, for the analysis of T cell infiltration of solid tumors and tissue, as well as infectious diseases, and for use in connection with toxicological studies, transplantation, immune monitoring, and vaccines and T cell monitoring, all for medical and veterinary purposes.

Classification kind code

11

Class [042]
Scientific and technological analyses of T cells and their responses, namely research services and design of T cells and their responses; industrial analysis of T cells and their responses, namely for development of medicines and vaccines; basic and clinical research on T cells and their responses, namely for the development of medicines and vaccines.

Classification kind code

11

Mark Details

Serial Number

2111343

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 231
on 1st Dec 2022		Limitation
Submitted for opposition 22
on 6th Sept 2022		Search Recorded
Submitted for opposition 20
on 6th Sept 2022		Examiner's First Report
Submitted for opposition 223
on 6th Sept 2022		Total Provisional Refusal
Submitted for opposition 256
on 4th Apr 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 3rd Jun 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 2th Jun 2021		Created
Submitted for opposition 31
on 2th Jun 2021		Formalized
Submitted for opposition 30
on 11th Feb 2021		Filed
Submitted for opposition 228
on 11th Feb 2021		International Registration